BLOMSTER I HJERTING ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  3.6% 3.6% 3.6% 3.6% 3.6%  
Bankruptcy risk  3.2% 2.9% 4.7% 3.5% 3.3%  
Credit score (0-100)  55 57 45 52 54  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  1,831 2,162 1,904 2,269 2,412  
EBITDA  380 550 247 157 418  
EBIT  301 455 136 55.4 317  
Pre-tax profit (PTP)  328.0 374.3 52.3 284.2 173.8  
Net earnings  254.4 290.1 39.3 219.6 133.3  
Pre-tax profit without non-rec. items  328 374 52.3 284 174  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  3,871 4,308 4,383 4,299 4,197  
Shareholders equity total  765 1,055 1,094 1,314 1,447  
Interest-bearing liabilities  2,454 2,808 2,948 2,413 2,411  
Balance sheet total (assets)  4,377 4,893 4,926 4,868 4,953  

Net Debt  2,330 2,628 2,932 2,411 2,407  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,831 2,162 1,904 2,269 2,412  
Gross profit growth  22.4% 18.1% -11.9% 19.2% 6.3%  
Employees  6 6 7 6 6  
Employee growth %  20.0% 0.0% 16.7% -14.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,377 4,893 4,926 4,868 4,953  
Balance sheet change%  1.1% 11.8% 0.7% -1.2% 1.8%  
Added value  380.5 550.5 247.3 166.4 418.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -158 342 -35 -186 -203  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  16.5% 21.1% 7.2% 2.4% 13.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.2% 9.8% 2.8% 7.8% 6.4%  
ROI %  11.1% 12.2% 3.3% 9.8% 8.4%  
ROE %  39.9% 31.9% 3.7% 18.2% 9.7%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  17.5% 21.6% 22.2% 27.0% 29.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  612.5% 477.4% 1,185.6% 1,535.2% 575.3%  
Gearing %  320.9% 266.2% 269.5% 183.7% 166.7%  
Net interest  0 0 0 0 0  
Financing costs %  2.5% 3.1% 2.9% 3.6% 5.9%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.2 0.3 0.3 0.3 0.4  
Current Ratio  0.4 0.5 0.4 0.4 0.5  
Cash and cash equivalent  123.4 180.2 16.8 1.7 4.2  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -935.7 -667.0 -920.5 -1,027.8 -864.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  63 92 35 28 70  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  63 92 35 26 70  
EBIT / employee  50 76 19 9 53  
Net earnings / employee  42 48 6 37 22